Eric Shiozaki

Eric Shiozaki is currently a Partner at DCVC Bio, with previous experience as a Partner at Novo Holdings and a Director at Apposite Capital. Prior to this, Eric held various roles at companies such as VitaPath Genetics and Burrill & Company. Eric also has a Ph.D. in Molecular Biology from Princeton University and a BA in Biophysics from The Johns Hopkins University.